GlucoTrack EBIT Margin 2011-2025 | GCTK

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

GlucoTrack ebit margin from 2011 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

GlucoTrack ebit margin from 2011 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$229B
Boston Scientific (BSX)	$157.6B
Stryker (SYK)	$150.8B
EssilorLuxottica (ESLOY)	$144B
Medtronic (MDT)	$118.3B
Lonza Group Ag (LZAGY)	$50.6B
Haleon (HLN)	$43.2B
ResMed (RMD)	$41.8B
GE HealthCare Technologies (GEHC)	$33.8B
Agilent Technologies (A)	$33.6B
Koninklijke Philips (PHG)	$26.8B
Terumo (TRUMY)	$26.5B
Insulet (PODD)	$23.4B
Zimmer Biomet Holdings (ZBH)	$21.3B
Smith & Nephew SNATS (SNN)	$16.3B
Baxter (BAX)	$12.6B
Sunny Optical Technology (SNPTF)	$10.8B
Demant (WILYY)	$8.1B
Bio-Rad Laboratories (BIO)	$8B
Lantheus Holdings (LNTH)	$3.8B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Prestige Consumer Healthcare (PBH)	$3.3B
Perrigo (PRGO)	$3.3B
ICU Medical (ICUI)	$3.1B
Haemonetics (HAE)	$2.7B
LeMaitre Vascular (LMAT)	$2.2B
Acuren (TIC)	$2.2B
Curaleaf Holdings (CURLF)	$2.1B
QuidelOrtho (QDEL)	$1.9B